Molecular mechanisms of [18F]fluorodeoxyglucose accumulation in liver cancer
- 29 November 2013
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 31 (2), 701-706
- https://doi.org/10.3892/or.2013.2886
Abstract
To elucidate the molecular mechanisms underlying the insufficient sensitivity in the detection of hepatocellular carcinoma (HCC) by [18F] 2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET), the characteristics of glucose metabolism-related protein expression in HCC were examined in liver metastasis from colorectal cancer (Meta). Thirty-four patients (14 Meta and 20 HCC) who underwent FDG-PET and hepatectomy were studied. The relationships between the maximum standardized uptake value (SUV) in tumors and the mRNA expression of glucose metabolism-related proteins [hexokinase (HK), glucose transporter 1 (GLUT1), and glucose-6-phosphatase (G6Pase)] and proliferating cell nuclear antigen (PCNA) were examined in snap-frozen specimens with quantitative PCR. Tumor detection rates were lower in HCC (15/20) compared to Meta (13/14) patients. HK and GLUT1 expression was lower and G6Pase expression was higher in HCC compared to Meta. In particular, GLUT1 overexpression was 92-fold in Meta and 11-fold in HCC compared to the surrounding liver. The SUV correlated with GLUT1 and PCNA expression in HCC, but not Meta patients. Of note, four cases of poorly differentiated (P/D) HCC compared to moderately differentiated (M/D) HCC produced completely different results for FDG uptake (SUV, 14.4 vs. 4.0) and mRNA expression (G6Pase expression, 0.007 vs. 1.5). Variations in the expression of glucose metabolism-related enzymes between HCC and Meta patients are attributed to origin or degree of differentiation. Low FDG uptake in M/D HCC reflected low GLUT1 and high G6Pase expression, while high FDG accumulation in P/D HCC could reflect increased GLUT1 and decreased G6Pase expression. These results may explain why M/D HCC is not detected as sensitively by FDG-PET.Keywords
This publication has 27 references indexed in Scilit:
- Comparison of preoperative whole‐body positron emission tomography with MDCT in patients with primary colorectal cancerColorectal Disease, 2009
- Multimodality imaging: an update on PET/CT technologyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- Imaging and cancer: A reviewMolecular Oncology, 2008
- Detection of recurrent rectal cancer with CT, MRI and PET/CTEuropean Radiology, 2007
- Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Predicts Tumor Differentiation, P-glycoprotein Expression, and Outcome after Resection in Hepatocellular CarcinomaClinical Cancer Research, 2007
- Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findingsLiver International, 2006
- 18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinomaThe Esophagus, 2004
- Positron emission tomography scanning in the evaluation of hepatocellular carcinomaJournal of Hepatology, 2000
- Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumorsAnnals of Nuclear Medicine, 2000
- Fluorine-18 Fdg Positron Emission Tomography for Imaging of Hepatocellular CarcinomaAmerican Journal Of Gastroenterology, 1999